-
Je něco špatně v tomto záznamu ?
Cardiac immune cell infiltration associates with abnormal lipid metabolism
V. Cifarelli, O. Kuda, K. Yang, X. Liu, RW. Gross, TA. Pietka, GS. Heo, D. Sultan, H. Luehmann, J. Lesser, M. Ross, IJ. Goldberg, RJ. Gropler, Y. Liu, NA. Abumrad
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
R01 HL045095
NHLBI NIH HHS - United States
NLK
Directory of Open Access Journals
od 2014
PubMed Central
od 2014
Europe PubMed Central
od 2014
Open Access Digital Library
od 2014-01-01
Open Access Digital Library
od 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2014
PubMed
36061565
DOI
10.3389/fcvm.2022.948332
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
CD36 mediates the uptake of long-chain fatty acids (FAs), a major energy substrate for the myocardium. Under excessive FA supply, CD36 can cause cardiac lipid accumulation and inflammation while its deletion reduces heart FA uptake and lipid content and increases glucose utilization. As a result, CD36 was proposed as a therapeutic target for obesity-associated heart disease. However, more recent reports have shown that CD36 deficiency suppresses myocardial flexibility in fuel preference between glucose and FAs, impairing tissue energy balance, while CD36 absence in tissue macrophages reduces efferocytosis and myocardial repair after injury. In line with the latter homeostatic functions, we had previously reported that CD36-/- mice have chronic subclinical inflammation. Lipids are important for the maintenance of tissue homeostasis and there is limited information on heart lipid metabolism in CD36 deficiency. Here, we document in the hearts of unchallenged CD36-/- mice abnormalities in the metabolism of triglycerides, plasmalogens, cardiolipins, acylcarnitines, and arachidonic acid, and the altered remodeling of these lipids in response to an overnight fast. The hearts were examined for evidence of inflammation by monitoring the presence of neutrophils and pro-inflammatory monocytes/macrophages using the respective positron emission tomography (PET) tracers, 64Cu-AMD3100 and 68Ga-DOTA-ECL1i. We detected significant immune cell infiltration in unchallenged CD36-/- hearts as compared with controls and immune infiltration was also observed in hearts of mice with cardiomyocyte-specific CD36 deficiency. Together, the data show that the CD36-/- heart is in a non-homeostatic state that could compromise its stress response. Non-invasive immune cell monitoring in humans with partial or total CD36 deficiency could help evaluate the risk of impaired heart remodeling and disease.
Department of Medicine Washington University School of Medicine St Louis MO United States
Department of Radiology Washington University School of Medicine St Louis MO United States
Institute of Physiology Czech Academy of Sciences Prague Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22023506
- 003
- CZ-PrNML
- 005
- 20221031095218.0
- 007
- ta
- 008
- 221010s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fcvm.2022.948332 $2 doi
- 035 __
- $a (PubMed)36061565
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Cifarelli, Vincenza $u Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States $u Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, United States
- 245 10
- $a Cardiac immune cell infiltration associates with abnormal lipid metabolism / $c V. Cifarelli, O. Kuda, K. Yang, X. Liu, RW. Gross, TA. Pietka, GS. Heo, D. Sultan, H. Luehmann, J. Lesser, M. Ross, IJ. Goldberg, RJ. Gropler, Y. Liu, NA. Abumrad
- 520 9_
- $a CD36 mediates the uptake of long-chain fatty acids (FAs), a major energy substrate for the myocardium. Under excessive FA supply, CD36 can cause cardiac lipid accumulation and inflammation while its deletion reduces heart FA uptake and lipid content and increases glucose utilization. As a result, CD36 was proposed as a therapeutic target for obesity-associated heart disease. However, more recent reports have shown that CD36 deficiency suppresses myocardial flexibility in fuel preference between glucose and FAs, impairing tissue energy balance, while CD36 absence in tissue macrophages reduces efferocytosis and myocardial repair after injury. In line with the latter homeostatic functions, we had previously reported that CD36-/- mice have chronic subclinical inflammation. Lipids are important for the maintenance of tissue homeostasis and there is limited information on heart lipid metabolism in CD36 deficiency. Here, we document in the hearts of unchallenged CD36-/- mice abnormalities in the metabolism of triglycerides, plasmalogens, cardiolipins, acylcarnitines, and arachidonic acid, and the altered remodeling of these lipids in response to an overnight fast. The hearts were examined for evidence of inflammation by monitoring the presence of neutrophils and pro-inflammatory monocytes/macrophages using the respective positron emission tomography (PET) tracers, 64Cu-AMD3100 and 68Ga-DOTA-ECL1i. We detected significant immune cell infiltration in unchallenged CD36-/- hearts as compared with controls and immune infiltration was also observed in hearts of mice with cardiomyocyte-specific CD36 deficiency. Together, the data show that the CD36-/- heart is in a non-homeostatic state that could compromise its stress response. Non-invasive immune cell monitoring in humans with partial or total CD36 deficiency could help evaluate the risk of impaired heart remodeling and disease.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kuda, Ondrej $u Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Yang, Kui $u Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States $u Division of Complex Drug Analysis, Office of Testing and Research, U.S. Food and Drug Administration, St. Louis, MO, United States
- 700 1_
- $a Liu, Xinping $u Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Gross, Richard W $u Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Pietka, Terri A $u Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Heo, Gyu Seong $u Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Sultan, Deborah $u Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Luehmann, Hannah $u Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Lesser, Josie $u Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Ross, Morgan $u Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Goldberg, Ira J $u Division of Endocrinology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States
- 700 1_
- $a Gropler, Robert J $u Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Liu, Yongjian $u Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States
- 700 1_
- $a Abumrad, Nada A $u Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States $u Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, United States
- 773 0_
- $w MED00198704 $t Frontiers in cardiovascular medicine $x 2297-055X $g Roč. 9, č. - (2022), s. 948332
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36061565 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20221010 $b ABA008
- 991 __
- $a 20221031095216 $b ABA008
- 999 __
- $a ind $b bmc $g 1853890 $s 1174794
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 9 $c - $d 948332 $e 20220817 $i 2297-055X $m Frontiers in cardiovascular medicine $n Front Cardiovasc Med $x MED00198704
- GRA __
- $a R01 HL045095 $p NHLBI NIH HHS $2 United States
- LZP __
- $a Pubmed-20221010